Showing results (971-980 of 1,006) with videos related to
Sort By:
Pageof 101
Annals of Surgical Oncology|March 2, 2023
Plasma Exosome Gene Signature Differentiates Colon Cancer from Healthy ControlsPaul A Vallejos, Amber Gonda, Jingjing Yu, et al.Frontiers in Psychiatry|August 23, 2021
Clinical Reasoning in Forensic Psychiatry: Concepts, Processes, and PitfallsNatalia Widiasih Raharjanti, Tjhin Wiguna, Agus Purwadianto, et al.Journal of Pathology Informatics|December 9, 2021
QuPath Digital Immunohistochemical Analysis of Placental TissueAshley L Hein, Maheswari Mukherjee, Geoffrey A Talmon, et al.Nucleic Acids Research|November 4, 2009
Ensembl Genomes: extending Ensembl across the taxonomic spaceP J Kersey, D Lawson, E Birney, et al.Future Oncology (London, England)|March 28, 2025
S2303: phase II/III trial of paclitaxel + ramucirumab ± nivolumab in gastric and esophageal adenocarcinoma (PARAMUNE)Anwaar Saeed, Sarah Colby, Paul Eliezer Oberstein, et al.NPJ Systems Biology and Applications|June 5, 2026
Optimizing genomics-aware clinical agents in precision oncologyRangan Das, K Maheswari, Shaheen Siddiqui, et al.Healthcare (Basel, Switzerland)|November 14, 2023
Physicians' Perspectives on HL7 Information Policy Sensitive Value Set: A Validation Study through Health Concept CategorizationMaheswari Eluru, Daniel Hector Mendoza, Audrey Wong, et al.ACS Chemical Biology|January 14, 2011
Alkylation of cysteine 468 in Stat3 defines a novel site for therapeutic developmentRalf Buettner, Renzo Corzano, Rumana Rashid, et al.Nucleic Acids Research|November 10, 2011
Ensembl Genomes: an integrative resource for genome-scale data from non-vertebrate speciesPaul J Kersey, Daniel M Staines, Daniel Lawson, et al.NPJ Precision Oncology|March 12, 2025
A phase II trial of mTORC1/2 inhibition in STK11 deficient non small cell lung cancerGary Middleton, Helen L Robbins, Peter Fletcher, et al.Pageof 101